GlassScriptPhysician profile
William M Liu
NPI 1013022722
$5,460.41
in general payments reported to CMS, 2019-2025
10 companies · $516 in 2025
The $516 reported for 2025 was less than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $454 · 2020: $314 · 2021: $749 · 2022: $576 · 2023: $2,258 · 2024: $594 · 2025: $516.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,620 · Food and Beverage: $1,454 · Education: $294.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,620.00 |
| Food and Beverage | $1,453.65 |
| Education | $293.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $3,040.38 | 2020-2025 | Tremfya, Simponi Aria |
| Abbvie INC. | $904.74 | 2019-2025 | |
| Glaxosmithkline, LLC. | $378.86 | 2019-2022 | |
| Aurinia Pharma U.S., INC. | $338.57 | 2021-2023 | Lupkynis |
| Novartis Pharmaceuticals Corporation | $225.69 | 2023-2025 | |
| Janssen Scientific Affairs, LLC | $210.11 | 2021-2022 | |
| Argenx US, INC. | $137.26 | 2025 | Vyvgart Hytrulo |
| Amgen INC. | $112.19 | 2019 | |
| Horizon Therapeutics Plc | $87.64 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $24.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.